Meta‐analysis: anti‐viral therapy of hepatitis C virus‐related liver disease in renal transplant patients

200699 citationsReview

Authors

G. Lunghi · Istituti di Ricovero e Cura a Carattere Scientifico

V. K. Dixit · University of California, Los Angeles

Abstract

Interferon-based therapy of hepatitis C has poor tolerance and safety after renal transplant. The optimal treatment of hepatitis C after renal transplant requires additional agents or alternative therapeutic approaches.

Topics & Keywords

Hepatitis C virus research Liver Disease and Transplantation Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alimentary Pharmacology & Therapeutics

Volume 24, Issue 10, pp. 1413-1422

DOI: 10.1111/j.1365-2036.2006.03151.x

Field-Weighted Citation Impact: 5.25

Command Palette